PD
Patrick Donnelly Citigroup Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
45
Avg Return
Past Year
Past Year
11%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
66.7%
Neutral
33.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Health Information Services
Medical Devices
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $265 |
21%
upside
| 1 | +20% |
0
%
| 16 Jan ‘26 2 days ago |
|
|
|
Neutral
Maintained
| $53 |
10%
upside
| 1 | -0.03% |
0
%
| 16 Jan ‘26 2 days ago |
|
|
|
Buy
Initiated
| $48 |
9%
upside
| 1 | +8.9% |
0
%
| 12 Jan ‘26 6 days ago |
|
|
|
Buy
Initiated
| $300 |
30%
upside
| 1 | -7% |
0
%
| 7 Jan ‘26 11 days ago |
|
|
|
Buy
Maintained
| $135 |
20%
upside
| 2 | +26% |
0
%
| 11 Dec ‘25 1 month ago |
|
|
|
Neutral
Downgraded
| $18 |
12%
downside
| 1 | +30% |
0
%
| 11 Dec ‘25 1 month ago |
|
|
|
Buy
Upgraded
| $660 |
7%
upside
| 2 | +7.8% |
0
%
| 11 Dec ‘25 1 month ago |
|
|
|
Neutral
Downgraded
| $50 |
5%
upside
| 1 | – |
–
| 11 Dec ‘25 1 month ago |
|
|
|
Buy
Upgraded
| $21 |
27%
upside
| 1 | +9% |
0
%
| 11 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $185 |
32%
upside
| 1 | -9.1% |
0
%
| 25 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $1,700 |
16%
upside
| 1 | +13% |
0
%
| 10 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $375 |
20%
upside
| 1 | +16% |
0
%
| 30 Oct ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $230 |
3%
downside
| 1 | – |
–
| 29 Oct ‘25 2 months ago |
|